Trail Ridge Investment Advisors LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,500 shares of the medical device company’s stock, valued at approximately $753,000.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Avalon Trust Co acquired a new stake in Cooper Companies in the second quarter worth $25,000. Root Financial Partners LLC boosted its holdings in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. grew its position in shares of Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the last quarter. Elevation Wealth Partners LLC grew its position in shares of Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp acquired a new stake in shares of Cooper Companies in the 2nd quarter worth about $32,000. 24.39% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
COO has been the topic of several recent research reports. UBS Group assumed coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price objective on the stock. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Needham & Company LLC cut their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research report on Wednesday, May 27th. Finally, Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Hold” and a consensus price target of $81.64.
Cooper Companies Stock Performance
Shares of COO opened at $75.80 on Tuesday. The firm has a 50-day moving average price of $72.09 and a 200 day moving average price of $71.07. The firm has a market capitalization of $14.78 billion, a PE ratio of 64.24, a P/E/G ratio of 1.99 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.
About Cooper Companies
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Stories
- Five stocks we like better than Cooper Companies
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
